- Home
- SPRY vs WLKP Comparison
SPRY vs WLKP Comparison
Compare SPRY & WLKP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SPRY | WLKP |
|---|---|---|
| Founded | 2015 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 823.2M | 778.9M |
| IPO Year | 2020 | 2014 |
Fundamental Metrics
Financial Performance| Metric | SPRY | WLKP |
|---|---|---|
| Price | $7.83 | $22.71 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $40.00 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 18.9K |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 8.25% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $84,278,000.00 | ★ $1,166,695,000.00 |
| Revenue This Year | $87.40 | $19.48 |
| Revenue Next Year | $81.64 | $5.24 |
| P/E Ratio | ★ N/A | $15.30 |
| Revenue Growth | N/A | ★ 2.71 |
| 52 Week Low | $6.66 | $17.75 |
| 52 Week High | $18.63 | $23.46 |
Technical Indicators
Market Signals| Indicator | SPRY | WLKP |
|---|---|---|
| Relative Strength Index (RSI) | 41.81 | 54.28 |
| Support Level | $7.20 | $21.70 |
| Resistance Level | $8.61 | $22.60 |
| Average True Range (ATR) | 0.39 | 0.40 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 19.23 | 50.60 |
Price Performance
Historical ComparisonAbout SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.
About WLKP Westlake Chemical Partners LP
Westlake Chemical Partners LP is a part of the chemical industry in the United States. Its operations are conducted through OpCo, it acquires and develops ethylene production facilities, which convert ethane into ethylene. OpCo sells ethylene and its co-products, such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen, to Westlake and other customers located in the United States. Its assets include three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana.